1-Deoxy- d -xylulose 5-phosphate reductoisomerase as target for anti Toxoplasma gondii agents: crystal structure, biochemical characterization and biological evaluation of inhibitors
Biochemical Journal · 2024
DOI: 10.1042/bcj20240110 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical Journal, 2024. Verfasst von Flaminia Mazzone und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medical Microbiology and Hospital Hygiene, Heinrich Heine University, Düsseldorf, Germany. Hauptthemen laut MEDLINE: Toxoplasma, Aldose-Ketose Isomerases, Fosfomycin, Multienzyme Complexes. Die Arbeit nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Toxoplasma gondii is a widely distributed apicomplexan parasite causing toxoplasmosis, a critical health issue for immunocompromised individuals and for congenitally infected foetuses. Current treatment options are limited in number and associated with severe side effects. Thus, novel anti-toxoplasma agents need to be identified and developed. 1-Deoxy-d-xylulose 5-phosphate reductoisomerase (DXR) is considered the rate-limiting enzyme in the non-mevalonate pathway for the biosynthesis of the isoprenoid precursors isopentenyl pyrophosphate and dimethylallyl pyrophosphate in the parasite, and has been previously investigated for its key role as a novel drug target in some species, encompassing Plasmodia, Mycobacteria and Escherichia coli. In this study, we present the first crystal structure of T. gondii DXR (TgDXR) in a tertiary complex with the inhibitor fosmidomycin and the cofactor NADPH in dimeric conformation at 2.5 Å resolution revealing the inhibitor binding mode. In addition, we biologically characterize reverse α-phenyl-β-thia and β-oxa fosmidomycin analogues and show that some derivatives are strong inhibitors of TgDXR which also, in contrast with fosmidomycin, inhibit the growth of T. gondii in vitro. Here, ((3,4-dichlorophenyl)((2-(hydroxy(methyl)amino)-2-oxoethyl)thio)methyl)phosphonic acid was identified as the most potent anti T. gondii compound. These findings will enable the future design and development of more potent anti-toxoplasma DXR inhibitors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Medical Microbiology and Hospital Hygiene, Heinrich Heine University, Düsseldorf, Germany.
- University Hospital Düsseldorf, Düsseldorf, Germany.
- Center for Structural Studies, Heinrich Heine University, Düsseldorf, Germany.
- Institute of Pharmaceutical and Medicinal Chemistry, Heinrich Heine University, Düsseldorf, Germany.
- National Research Centre (NRC), Dokki, Cairo, Egypt.
- Institute of Biochemistry, Heinrich Heine University, Düsseldorf, Germany.
ORCID-Profile: Flaminia Mazzone, Daniel Degrandi, Klaus Pfeffer
Förderung
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Mazzone, F., Hoeppner, A., Reiners, J., Gertzen, C. G. W., Applegate, V., Abdullaziz, M. A., Gottstein, J., Degrandi, D., Wesemann, M., Kurz, T., Smits, S. H. J., & Pfeffer, K. (2024). 1-Deoxy- d -xylulose 5-phosphate reductoisomerase as target for anti Toxoplasma gondii agents: crystal structure, biochemical characterization and biological evaluation of inhibitors. Biochemical Journal. https://doi.org/10.1042/bcj20240110
Vancouver
Mazzone F, Hoeppner A, Reiners J, Gertzen CGW, Applegate V, Abdullaziz MA, et al. 1-Deoxy- d -xylulose 5-phosphate reductoisomerase as target for anti Toxoplasma gondii agents: crystal structure, biochemical characterization and biological evaluation of inhibitors. Biochemical Journal. 2024. doi:10.1042/bcj20240110
BibTeX
@article{Mazzone2024,
author = {Mazzone, Flaminia and Hoeppner, Astrid and Reiners, Jens and Gertzen, Christoph G W and Applegate, Violetta and Abdullaziz, Mona A and Gottstein, Julia and Degrandi, Daniel and Wesemann, Martina and Kurz, Thomas and Smits, Sander H J and Pfeffer, Klaus},
title = {1-Deoxy- d -xylulose 5-phosphate reductoisomerase as target for anti Toxoplasma gondii agents: crystal structure, biochemical characterization and biological evaluation of inhibitors},
journal = {Biochemical Journal},
year = {2024},
doi = {10.1042/bcj20240110}
}
EUVIMED